Chickenpox, caused by the varicella-zoster virus (VZV), is a highly contagious viral infection primarily affecting children. The characteristic symptom of chickenpox is a widespread itchy rash that progresses from red spots to fluid-filled blisters before forming scabs and ultimately healing. Other common symptoms include fever, headache, and fatigue. While chickenpox is generally a mild and self-limiting disease, complications can arise, particularly in immunocompromised individuals and adults. Serious complications may include bacterial skin infections, pneumonia, and, in rare cases, encephalitis. Pregnant women who contract chickenpox are also at risk of complications affecting both the mother and the developing fetus. Prevention strategies involve vaccination with the varicella vaccine, typically administered during childhood, and post-exposure prophylaxis for individuals at high risk of severe disease. Understanding the symptoms, complications, and preventive measures associated with chickenpox is essential for effective public health management and reducing the overall burden of this contagious viral infection.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain